stockportfolio.pro
Agilent Technologies, Inc. (A)
Healthcare · Diagnostics & Research · NYSE
Agilent Technologies, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.20B | $4.47B | $4.91B | $5.16B | $5.34B | $6.32B | $6.85B | $6.83B | $6.51B | $6.95B |
| Gross profit | $2.20B | $2.41B | $2.68B | $2.81B | $2.84B | $3.41B | $3.72B | $3.46B | $3.54B | $3.64B |
| Net income | $462.00M | $684.00M | $316.00M | $1.07B | $719.00M | $1.21B | $1.25B | $1.24B | $1.29B | $1.30B |
| Net margin | 11.0% | 15.3% | 6.4% | 20.7% | 13.5% | 19.1% | 18.3% | 18.1% | 19.8% | 18.8% |
Source: Agilent Technologies, Inc. SEC filings (10-K). 19 years of history available in the interactive view.
What growth is priced into A stock?
At today's market cap of $38.26B, Agilent Technologies, Inc. is priced for free-cash-flow growth of about 14.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.15B from the FY ending 2025-10-31). For comparison, free cash flow actually grew 7.5%/yr over the last five fiscal years and revenue 5.4%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 19 years of Agilent Technologies, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeAgilent Technologies, Inc. financial history by metric
About Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Agilent Technologies, Inc. — frequently asked questions
What is Agilent Technologies, Inc.'s revenue?
Agilent Technologies, Inc. (A) reported revenue of $6.95B for fiscal year 2025, up 6.7% from the prior year, according to its SEC filings.
Is Agilent Technologies, Inc. profitable?
Yes. A earned net income of $1.30B in fiscal 2025, a net margin of 18.8%.
What is A's P/E ratio?
Agilent Technologies, Inc. trades at a price-to-earnings ratio of about 26.7 based on the latest data in our nightly-refreshed cache.
How fast is Agilent Technologies, Inc. growing?
A's revenue grew at roughly 5.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Agilent Technologies, Inc. have?
As of fiscal year 2025, A carried roughly $3.35B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Agilent Technologies, Inc.'s gross margin?
A's gross margin was 52.4% in fiscal 2025 — gross profit of $3.64B on revenue of $6.95B.
What is Agilent Technologies, Inc.'s market cap?
Agilent Technologies, Inc. (A) has a market capitalization of about $38.26B, based on the latest data in our nightly-refreshed cache.
When does Agilent Technologies, Inc.'s fiscal year end?
A's fiscal year ends in October. Its most recent annual filing covers the fiscal year ending 2025-10-31.
What growth is priced into A stock?
At today's market cap of $38.26B, Agilent Technologies, Inc. is priced for free-cash-flow growth of about 14.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.15B from the FY ending 2025-10-31). For comparison, free cash flow actually grew 7.5%/yr over the last five fiscal years and revenue 5.4%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Agilent Technologies, Inc.'s official SEC filings (10-K and 10-Q), covering 19 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.